| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 132.412 | 519.415 | 768.793 | 710.717 | 592.441 |
| Total Income - EUR | - | - | - | - | - | 132.586 | 519.420 | 768.793 | 734.468 | 607.055 |
| Total Expenses - EUR | - | - | - | - | - | 54.835 | 266.123 | 402.622 | 460.039 | 498.364 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 77.751 | 253.296 | 366.171 | 274.429 | 108.691 |
| Net Profit/Loss - EUR | - | - | - | - | - | 76.426 | 248.531 | 358.483 | 263.160 | 90.109 |
| Employees | - | - | - | - | - | 0 | 8 | 10 | 14 | 11 |
Check the financial reports for the company - Razedent Total Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 34.829 | 68.278 | 79.678 | 246.418 | 353.254 |
| Current Assets | - | - | - | - | - | 43.038 | 187.315 | 363.149 | 352.131 | 323.555 |
| Inventories | - | - | - | - | - | 11.335 | 25.477 | 32.079 | 87.944 | 2.734 |
| Receivables | - | - | - | - | - | 0 | 74.440 | 2.131 | 3.991 | 88.348 |
| Cash | - | - | - | - | - | 31.703 | 87.398 | 328.939 | 260.195 | 232.474 |
| Shareholders Funds | - | - | - | - | - | 76.467 | 248.571 | 358.524 | 565.697 | 652.645 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 1.399 | 7.022 | 84.303 | 32.852 | 24.164 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Razedent Total Med S.r.l.